BeyondSpring stock more than triples after lung cancer treatment meets endpoints in Phase 3 trial
Shares of BeyondSpring Inc.
BYSI,
+1.58%
more than tripled — up 242% — on heavy volume in premarket trading Wednesday, after the New York-headquartered biopharmaceutical company said a Phase 3 trial of its lung cancer treatment met the primary and…
